Tuberculosis Detection Market

Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.

Tuberculosis (TB) is a chronic and slow - onset infectious disease in young people.The incubation period is 4 to 8 weeks.Of these, 80% occur in the lungs, and other areas (cervical lymph, meninges, peritoneum, intestine, skin, bone) may also be secondary to infection.Transmission of respiratory tract from person to person is the main mode of transmission.Infection source is the person that contacts the tuberculosis that discharges bacterium.With the spread of environmental pollution and AIDS, the incidence of TB is becoming more and more intense.In addition to a few cases of rapid onset, clinical more chronic process.There are often low fever, fatigue and other systemic symptoms and respiratory symptoms such as cough, hemoptysis.

Tuberculosis Detection Market contains market size and forecasts of Tuberculosis (TB) Detection in Global, including the following market information:

Global Tuberculosis (TB) Detection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Tuberculosis (TB) Detection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Bacterial Culture Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Tuberculosis (TB) Detection include Danaher, Roche, Thermal Fisher, Abbott, Oxford Immunotec International, Qiagen, Hologic, Hain Lifescience and Epistem and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Tuberculosis (TB) Detection companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tuberculosis (TB) Detection Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Tuberculosis (TB) Detection Market Segment Percentages, by Type, 2021 (%)

Bacterial Culture Test

Tuberculin Test

Rapid Molecular Diagnosis

Other

Global Tuberculosis (TB) Detection Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Tuberculosis (TB) Detection Market Segment Percentages, by Application, 2021 (%)

Hospital

Clinic

Research Institution

Other

Global Tuberculosis (TB) Detection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Tuberculosis (TB) Detection Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Tuberculosis (TB) Detection revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Tuberculosis (TB) Detection revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Danaher

Roche

Thermal Fisher

Abbott

Oxford Immunotec International

Qiagen

Hologic

Hain Lifescience

Epistem

Creative Diagnostics